Use of sedative and analgesic agents in neurotrauma patients: effects on cerebral physiology (Q34230318)

31 July 2017

1 reference

title

Use of sedative and analgesic agents in neurotrauma patients: effects on cerebral physiology (English)

1 reference

31 July 2017

0 references

1 reference

Rhoney DH

1

1 reference

PubMed ID

11320605

31 July 2017

Parker D Jr

series ordinal

2

1 reference

31 July 2017

1 March 2001

1 reference

31 July 2017

Neurological Research

1 reference

31 July 2017

23

1 reference

31 July 2017

2-3

1 reference

31 July 2017

237-259

1 reference

Controlled Sedation with Alphaxalone-Alphadolone

31 July 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Practical pharmacokinetics as applied to our daily anesthesia practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of omeprazole and cimetidine on plasma diazepam levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Prolonged sedation due to accumulation of conjugated metabolites of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Age and nature of operation influence the pharmacokinetics of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of midazolam in patients recovering from cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

A potentially hazardous interaction between erythromycin and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of aging and liver disease on disposition of lorazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Systemic and coronary hemodynamic effects of diazepam in patients with normal and diseased coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Frequent hypoxemia and apnea after sedation with midazolam and fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Midazolam/propofol but not propofol alone reversibly depress the swallowing reflex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effect of intravenously administered diazepam, midazolam and flumazenil on the sensitivity of upper airway reflexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Changes in cerebral blood velocity after intravenous diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Cerebral vasomotor responsiveness to carbon dioxide is preserved during propofol and midazolam anesthesia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of midazolam on cerebral hemodynamics and cerebral vasomotor responsiveness to carbon dioxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Auditory and electroencephalographic effects of midazolam and alpha-hydroxy-midazolam in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of flumazenil on cerebral blood flow and oxygen consumption after midazolam anaesthesia for craniotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effects of midazolam reversal by RO 15-1788 on cerebral perfusion pressure in patients with severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The touch of Morpheus: pre-20th century accounts of sleepy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of opioids in renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The metabolism and bioavailability of morphine in patients with severe liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Profound reduction in morphine clearance and liver blood flow in shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Central nervous system excitatory effects of meperidine in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

A comparison of the circulatory effects in man of the analgesics fentanyl, pentazocine and pethidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Protective effect of the vagotonic action of morphine sulphate on ventricular vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Cardiovascular effects of high-dose fentanyl anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Localization of brainstem sites which mediate alfentanil-induced muscle rigidity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Regulation of gastrointestinal function by multiple opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of Sufentanil on Cerebral Blood Flow, Cerebral Blood Flow Velocity, and Metabolism in Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of morphine and n-allylnormorphine on cerebral hemodynamics and oxygen metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of fentanyl, droperidol, and innovar on canine cerebral metabolism and blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effect of fentanyl, sufentanil, and alfentanil on cerebral arterioles in piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of sufentanil on intracranial pressure in neurosurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of alfentanil on cerebral haemodynamics in an experimental model of traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of sufentanil on cerebral circulation and metabolism in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Alfentanil-induced hypermetabolism, seizure, and histopathology in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Electroencephalographic effects of sufentanil anaesthesia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of high-dose pentobarbital in severe head trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacodynamics and pharmacokinetics of thiopental.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Barbiturates in brain ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pentobarbital coma in neurosurgical patients: nutrition considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Mechanisms of cerebral protection by pentobarbital and nizofenone correlated with the course of local cerebral blood flow changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Failure of prophylactic barbiturate coma in the treatment of severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Barbiturates in focal ischemia of primate cortex: effects on blood flow distribution, evoked potential and extracellular potassium

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Current concepts in cerebral protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Barbiturates for cerebral aneurysm surgery. A review of preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Disposition of propofol in patients undergoing surgery. A comparison in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of propofol (diprivan) in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetic model driven infusion of propofol in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Propofol for long-term sedation in the intensive care unit. A comparison with papaveretum and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Propofol in patients needing long-term sedation in intensive care: an assessment of the development of tolerance. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetic interaction of propofol and fentanyl: single bolus injection study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Haemodynamic changes during anaesthesia induced and maintained with propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The haemodynamic effects of intravenous induction. Comparison of the effects of thiopentone and propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The cardiorespiratory effects of ICI 35 868 in patients with valvular heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Ventilatory effects of propofol during induction of anaesthesia. Comparison with thiopentone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Some ventilatory effects of propofol as sole anaesthetic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of propofol on cerebral blood flow and metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of propofol on elevated intracranial pressure. Preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effects of propofol on cerebral high energy metabolites, lactate, and glucose in normoxic and severely hypoxic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Propofol infusion for sedation of patients with head injury in intensive care. A preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The comparative effects of propofol, thiopental, and diazepam, administered intravenously, on pentylenetetrazol seizure threshold in the rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Propofol infusion for the treatment of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Successful use of propofol in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Proprofol and the electroencephalogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarct size after temporary focal ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Mechanisms of etomidate potentiation of GABAA receptor-gated currents in cultured postnatal hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Profile of etomidate. A hypnotic, anticonvulsant and brain protective compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Cerebral blood flow and metabolism during etomidate anaesthesia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

A review of etomidate for rapid sequence intubation in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Vascular effects of etomidate administered for electroencephalographic burst suppression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Mortality amongst multiple trauma patients admitted to an intensive therapy unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Influence of sedation on mortality in critically ill multiple trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Solvent for etomidate may cause pain and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Haemolysis after etomidate: comparison of propylene glycol and lipid formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Etomidate: a clinical and electroencephalographic comparison with thiopental

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Intracranial pressure during induction of anaesthesia and tracheal intubation with etomidate-induced EEG burst suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Etomidate infusions for the control of refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Excitatory effects and electroencephalographic correlation of etomidate, thiopental, methohexital, and propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of etomidate on intracranial pressure and cerebral perfusion pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Cerebral electrical activity influences the effects of etomidate on cerebral perfusion pressure in traumatic coma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Comparison of etomidate and althesin in the reduction of increased intracranial pressure after head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Molecular actions of racemic ketamine on human CNS sodium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics and analgesic effect of ketamine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The cardiovascular response to ketamine: the effects of clonidine and lignocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Response to hypercapnia under ketamine anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Ketamine anaesthesia in patients with intracranial pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Ketamine/diazepam infusion anaesthesia with special attention to the effect on cerebrospinal fluid pressure and arterial blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Ketamine for analgosedative therapy in intensive care treatment of head-injured patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Modification of Ketamine-Induced Intracranial Hypertension in Neurosurgical Patients by Pretreatment with Midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Cerebral blood flow and metabolism following ketamine administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Ketamine anesthesia in brain-damaged epileptics: Electroencephalographic and clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Cardiovascular effects of droperidol during enflurane and enflurane — nitrous oxide anaesthesia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Torsades de Pointes associated with intravenous haloperidol in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Neuroleptic malignant syndrome in a trauma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Alpha 2-adrenergic agonists in cardiovascular anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacological properties of prejunctional α-adrenoceptors in isolated feline middle cerebral arteries; comparison with the postjunctional α-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effect of lesions in the locus coeruleus on the physiological responses of the cerebral blood vessels in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of dexmedetomidine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Alpha 2-adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Intracranial pressure effects of dexmedetomidine in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Dexmedetomidine decreases cerebral blood flow velocity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Histamine Release by Narcotics and Muscle Relaxants in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of renal impairment and hemodialysis on lorazepam kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effect of neurotrauma on hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Negative inotropic effects of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Drug infusion with a Paceport Swan-Ganz catheter during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Diazepam blocks cerebral metabolic and circulatory responses to local anesthetic-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of morphine sulfate in patients with burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Acute trauma alters morphine clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effects of meperidine, promethazine, and chlorpromazine on pulmonary and systemic circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

ED50 of alfentanil for induction of anesthesia in unpremedicated young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effects of high-dose fentanyl on cerebral circulation and metabolism in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The effect of alfentanil on cerebral blood flow velocity and intracranial pressure during isoflurane-nitrous oxide anesthesia in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Effects of High-dose Fentanyl Anesthesia on the Electroencephalogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pentobarbital pharmacokinetics in patients with severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The use of barbiturates in the control of intracranial hypertension. Brain Trauma Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Enhancement by propofol of the gamma-aminobutyric acidA response in dissociated hippocampal pyramidal neurons of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics and protein binding of propofol in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The Effects of Propofol on Brain Electrical Activity, Neurologic Outcome, and Neuronal Damage Following Incomplete Ischemia in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The nonhypnotic therapeutic applications of propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Activation of epileptogenic activity by etomidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

The pharmacokinetics of droperidol in anesthetized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Absorption, Metabolism and Excretion of Droperidol by Human Subjects Folloiwing Intramuscular and Intravenous Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

A STUDY OF SOME OF THE PHARMACOLOGIC ACTIONS OF DROPERIDOL

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164101101198398

10.1179/016164101101198398

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11320605